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Introduction
The cytoplasmic S100 proteins derived from cells of mye-
loid origin. Calprotectin (MRP8/14 protein complex)
might be a biomarker either for autoinflammation and
autoimmunopathy. Since autoinflammatory diseases might
be a diagnostic challenge calprotectin may be helpful in
the diagnosis of autoinflammatory diseases. Chronic non-
bacterial osteomyelitis (CNO) is an autoinflammatory,
noninfectious disease. CNO describes a wide spectrum
from a monofocal bone lesion to the chronic recurring
multifocal osteomyelitis (CRMO). Laboratory and
histopathological findings are nonspecific. In some
patients systemic inflammatory signs such as elevated
acute phase proteins cannot be found.
Objectives
To test the ability of Calprotectin (MRP8/14 protein
complex) serum concentrations to monitor disease activity
in patients with CNO.
Methods
Serum concentrations of Calprotectin (MRP8/14 protein
complex) in a patient with CNO were determined by a
sandwich ELISA.
Results
Calprotectin (MRP8/14) level were raised heralding active
disease when acute phase proteins (CrP, erythrocyte sedi-
mentation rate). The calprotectin level was 7872,7 ng/ml
(normal range 0-3000 ng/ml).
Conclusion
Calprotectin (MRP8/14) serum concentrations correlate
closely with disease activity and may herald a flare before
clinical manifestation. Therefore MRP8/14 serum concen-
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